264 related articles for article (PubMed ID: 26777752)
1. Impact of the introduction of a specialist critical care pharmacist on the level of pharmaceutical care provided to the critical care unit.
Richter A; Bates I; Thacker M; Jani Y; O'Farrell B; Edwards C; Taylor H; Shulman R
Int J Pharm Pract; 2016 Aug; 24(4):253-61. PubMed ID: 26777752
[TBL] [Abstract][Full Text] [Related]
2. Reducing medication errors in critical care patients: pharmacist key resources and relationship with medicines optimisation.
Bourne RS; Shulman R; Jennings JK
Int J Pharm Pract; 2018 Dec; 26(6):534-540. PubMed ID: 29314430
[TBL] [Abstract][Full Text] [Related]
3. PROTECTED-UK - Clinical pharmacist interventions in the UK critical care unit: exploration of relationship between intervention, service characteristics and experience level.
Rudall N; McKenzie C; Landa J; Bourne RS; Bates I; Shulman R
Int J Pharm Pract; 2017 Aug; 25(4):311-319. PubMed ID: 27699912
[TBL] [Abstract][Full Text] [Related]
4. Proactive clinical pharmacist interventions in critical care: effect of unit speciality and other factors.
Bourne RS; Choo CL; Dorward BJ
Int J Pharm Pract; 2014 Apr; 22(2):146-54. PubMed ID: 23763333
[TBL] [Abstract][Full Text] [Related]
5. Pharmacist's review and outcomes: Treatment-enhancing contributions tallied, evaluated, and documented (PROTECTED-UK).
Shulman R; McKenzie CA; Landa J; Bourne RS; Jones A; Borthwick M; Tomlin M; Jani YH; West D; Bates I;
J Crit Care; 2015 Aug; 30(4):808-13. PubMed ID: 25971871
[TBL] [Abstract][Full Text] [Related]
6. Impact of pharmacist-led medication management in care transitions.
Yang S
BMC Health Serv Res; 2017 Nov; 17(1):722. PubMed ID: 29132369
[TBL] [Abstract][Full Text] [Related]
7. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
MacLaren R; Bond CA
Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacist interventions on a UK neurosurgical critical care unit: a 2-week service evaluation.
Bourne RS; Dorward BJ
Int J Clin Pharm; 2011 Oct; 33(5):755-8. PubMed ID: 21833712
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of pharmacist clinical interventions in a Dutch hospital setting.
Bosma L; Jansman FG; Franken AM; Harting JW; Van den Bemt PM
Pharm World Sci; 2008 Jan; 30(1):31-8. PubMed ID: 17592752
[TBL] [Abstract][Full Text] [Related]
10. [A new joint approach to drug management: clinical pharmacy services and risk management unit].
Schwartz V; Kravitz MS
Harefuah; 2015 Apr; 154(4):228-32, 281. PubMed ID: 26065215
[TBL] [Abstract][Full Text] [Related]
11. Critical care pharmacy workforce: UK deployment and characteristics in 2015.
Borthwick M; Barton G; Bourne RS; McKenzie C
Int J Pharm Pract; 2018 Aug; 26(4):325-333. PubMed ID: 29024199
[TBL] [Abstract][Full Text] [Related]
12. Integrating a pharmacist into an anaesthesiology and critical care department: Is this worthwhile?
Chapuis C; Albaladejo P; Billon L; Catoire C; Chanoine S; Allenet B; Bouzat P; Bedouch P; Payen JF
Int J Clin Pharm; 2019 Dec; 41(6):1491-1498. PubMed ID: 31595449
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the impact of a tele-ICU pharmacist on the management of sedation in critically ill mechanically ventilated patients.
Forni A; Skehan N; Hartman CA; Yogaratnam D; Njoroge M; Schifferdecker C; Lilly CM
Ann Pharmacother; 2010 Mar; 44(3):432-8. PubMed ID: 20164471
[TBL] [Abstract][Full Text] [Related]
14. The critical care clinical pharmacist: evolution of an essential team member.
Horn E; Jacobi J
Crit Care Med; 2006 Mar; 34(3 Suppl):S46-51. PubMed ID: 16477202
[TBL] [Abstract][Full Text] [Related]
15. Interdisciplinary patient care in the intensive care unit: focus on the pharmacist.
Erstad BL; Haas CE; O'Keeffe T; Hokula CA; Parrinello K; Theodorou AA
Pharmacotherapy; 2011 Feb; 31(2):128-37. PubMed ID: 21275491
[TBL] [Abstract][Full Text] [Related]
16. Critical Care Pharmacists and Medication Management in an ICU Recovery Center.
Stollings JL; Bloom SL; Wang L; Ely EW; Jackson JC; Sevin CM
Ann Pharmacother; 2018 Aug; 52(8):713-723. PubMed ID: 29457491
[TBL] [Abstract][Full Text] [Related]
17. A primer on critical care pharmacy services.
Erstad BL
Ann Pharmacother; 2008 Dec; 42(12):1871-81. PubMed ID: 19017823
[TBL] [Abstract][Full Text] [Related]
18. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
Kopp BJ; Mrsan M; Erstad BL; Duby JJ
Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956
[TBL] [Abstract][Full Text] [Related]
19. Drug errors and related interventions reported by United States clinical pharmacists: the American College of Clinical Pharmacy practice-based research network medication error detection, amelioration and prevention study.
Kuo GM; Touchette DR; Marinac JS
Pharmacotherapy; 2013 Mar; 33(3):253-65. PubMed ID: 23378169
[TBL] [Abstract][Full Text] [Related]
20. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
